Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14953)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2015 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Zhang MM, Qian W, Qin YY, He J, Zhou YH. Probiotics in |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i14/4345.htm |
| Number | Citing Articles |
| 1 |
Moon Young Lee, Suck Chei Choi, Yong Sung Kim. The Role of Gut Microbiota and Use of Probiotics in the Treatment of Upper Gastrointestinal Diseases. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2019; 19(2): 99 doi: 10.7704/kjhugr.2019.19.2.99
|
| 2 |
Masoud Keikha, Hossein Kamali. The impact of Saccharomyces boulardii adjuvant supplementation on alternation of gut microbiota after H. pylori eradication; a metagenomics analysis. Gene Reports 2022; 26: 101499 doi: 10.1016/j.genrep.2022.101499
|
| 3 |
Shahram Agah, Abolfazl Akbari, Javad Heshmati, Mahdi Sepidarkish, Mojgan Morvaridzadeh, Payman Adibi, Mohsen Mazidi, Farnaz Farsi, Richard Ofori-Asenso, Nicholas J. Talley, Christine Feinle-Bisset. Systematic review with meta-analysis: Effects of probiotic supplementation on symptoms in functional dyspepsia. Journal of Functional Foods 2020; 68: 103902 doi: 10.1016/j.jff.2020.103902
|
| 4 |
Anthony O'Connor, Wolfgang Fischbach, Javier P. Gisbert, Colm O'Morain. Treatment of Helicobacter pylori infection 2016. Helicobacter 2016; 21(S1): 55 doi: 10.1111/hel.12342
|
| 5 |
Gilberto Jaramillo-Trujillo, William Alberto Otero-Regino, Kelly Patricia Estrada-Orozco. Efectividad y seguridad del uso de probióticos como adyuvantes en la erradicación de Helicobacter pylori. Revisión sistemática y metaanálisis. Revista de la Facultad de Medicina 2022; 71(2): e98018 doi: 10.15446/revfacmed.v71n2.98018
|
| 6 |
D. I. Trukhan. Disorders of intestinal microbiocenosis: expanding the application of probiotics. Meditsinskiy sovet = Medical Council 2022; (7): 132 doi: 10.21518/2079-701X-2022-16-7-132-143
|
| 7 |
N. L. Pakhomovskaia, O. F. Tatyanina, Т. Yu. Lazareva. Approaches to prevention of antibiotic-associated diarrhea in children. Meditsinskiy sovet = Medical Council 2021; (17): 283 doi: 10.21518/2079-701X-2021-17-1
|
| 8 |
Shiying Wu, Yang Xu, Ziqi Chen, Yongqiang Chen, Fangtong Wei, Chenlan Xia, Qingqing Zhou, Ping Li, Qing Gu. Lactiplantibacillus plantarum ZJ316 Reduces Helicobacter pylori Adhesion and Inflammation by Inhibiting the Expression of Adhesin and Urease Genes. Molecular Nutrition & Food Research 2023; 67(18) doi: 10.1002/mnfr.202300241
|
| 9 |
Jiahao Zhao, Yiqun Liao, Chen Wei, Yichao Ma, Fei Wang, Yuji Chen, Bin Zhao, Hao Ji, Daorong Wang, Dong Tang. Potential Ability of Probiotics in the Prevention and Treatment of Colorectal Cancer. Clinical Medicine Insights: Oncology 2023; 17 doi: 10.1177/11795549231188225
|
| 10 |
Serhat ÖCAL. Managing Helicobacter pylori infection: transitioning from conventional to alternative treatment approaches. The European Research Journal 2024; 10(1): 136 doi: 10.18621/eurj.1320819
|
| 11 |
Dhary Alewy Almashhadany, Mustafa Abdulmonam Zainel, Taha Talal AbdulRahman. Review of foodborne helicobacteriosis. Italian Journal of Food Safety 2024; doi: 10.4081/ijfs.2024.12176
|
| 12 |
I. Polanco Allué. Microbiota y enfermedades gastrointestinales. Anales de Pediatría 2015; 83(6): 443.e1 doi: 10.1016/j.anpedi.2015.07.034
|
| 13 |
Yi Hu, Yin Zhu, Nong-Hua Lu. Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance. Frontiers in Cellular and Infection Microbiology 2017; 7 doi: 10.3389/fcimb.2017.00168
|
| 14 |
Roberto Manzini, Michael Scharl. Bakterien, deine Freunde und Helfer?. Schweizer Gastroenterologie 2024; 5(3): 67 doi: 10.1007/s43472-024-00138-5
|
| 15 |
Ling Zhang, Ming Zhao, Xiangsheng Fu. Gastric microbiota dysbiosis and Helicobacter pylori infection. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1153269
|
| 16 |
Evariste Tshibangu-Kabamba, Yoshio Yamaoka. Helicobacter pylori infection and antibiotic resistance — from biology to clinical implications. Nature Reviews Gastroenterology & Hepatology 2021; 18(9): 613 doi: 10.1038/s41575-021-00449-x
|
| 17 |
Vali Musazadeh, Ahmad Nazari, Amir Hossein Faghfouri, Mohammad Emami, Zeynab Kavyani, Maryam Zokaei, Parmida Jamilian, Meysam Zarezadeh, Ahmad Saedisomeolia. The effectiveness of treatment with probiotics inHelicobacter pylorieradication: results from an umbrella meta-analysis on meta-analyses of randomized controlled trials. Food & Function 2023; 14(16): 7654 doi: 10.1039/D3FO00300K
|
| 18 |
Mehmet Mihmanli, Enver Ilhan, Ufuk Oguz Idiz, Ali Alemdar, Uygar Demir. Recent developments and innovations in gastric cancer. World Journal of Gastroenterology 2016; 22(17): 4307-4320 doi: 10.3748/wjg.v22.i17.4307
|
| 19 |
Sotirios D Georgopoulos, Vasilios Papastergiou, Stylianos Karatapanis. Treatment ofHelicobacter Pyloriinfection: optimization strategies in a high resistance era. Expert Opinion on Pharmacotherapy 2015; 16(15): 2307 doi: 10.1517/14656566.2015.1084503
|
| 20 |
Abstract(191) |
Core Tip(124) |
Full Article(HTML)(296)
|
全文 (PDF)-1522K(166)
|
Times Cited (0)
|
Total Visits (777)
|
Open
|
| 21 |
Xiaofen Bai, Minjie Zhu, Yajun He, Tengyan Wang, Da Tian, Jianchang Shu. The impacts of probiotics in eradication therapy of Helicobacter pylori. Archives of Microbiology 2022; 204(12) doi: 10.1007/s00203-022-03314-w
|
| 22 |
I. Polanco Allué. Microbiota and gastrointestinal diseases. Anales de Pediatría (English Edition) 2015; 83(6): 443.e1 doi: 10.1016/j.anpede.2015.11.003
|
| 23 |
Ankit Namdev, Dharmendra Jain. Floating Drug Delivery Systems: An Emerging Trend for the Treatment of Peptic Ulcer. Current Drug Delivery 2019; 16(10): 874 doi: 10.2174/1567201816666191018163519
|
| 24 |
Saumya Darshana Patra, Aryashree Arunima, Mrutyunjay Suar. Microbial Engineering for Therapeutics. 2022; : 3 doi: 10.1007/978-981-19-3979-2_1
|
| 25 |
Mariangela Rondanelli, Milena Anna Faliva, Simone Perna, Attilio Giacosa, Gabriella Peroni, Anna Maria Castellazzi. Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses. Gut Microbes 2017; 8(6): 521 doi: 10.1080/19490976.2017.1345414
|
| 26 |
Xinquan Li, Qiang Wang, Xiafen Hu, Wanxin Liu. Current Status of Probiotics as Supplements in the Prevention and Treatment of Infectious Diseases. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.789063
|
| 27 |
V. T. Ivashkin, I. V. Maev, T. L. Lapina, E. D. Fedorov, A. A. Sheptulin, A. S. Trukhmanov, A. V. Kononov, R. A. Abdulkhakov, O. P. Alexeeva, S. A. Alekseenko, D. N. Andreev, E. K. Baranskaya, N. N. Dekhnich, I. L. Klyaritskaya, R. S. Kozlov, E. A. Kogan, M. P. Korolev, N. V. Korochanskaya, S. A. Kurilovich, M. A. Livsan, M. F. Osipenko, P. V. Pavlov, S. S. Pirogov, A. S. Sarsenbaeva, V. I. Simanenkov, A. S. Tertychny, A. V. Tkachev, Yu. P. Uspensky, I. B. Khlynov, V. V. Tsukanov. Clinical Recommendations of Russian Gastroenterological Association and RENDO Endoscopic Society on Diagnosis and Treatment of Gastritis and Duodenitis. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2021; 31(4): 70 doi: 10.22416/1382-4376-2021-31-4-70-99
|
| 28 |
Zi-Juan Wang, Xiao-Feng Chen, Zi-Xiao Zhang, Yu-Chen Li, Juan Deng, Jing Tu, Zhi-Qiang Song, Qing-Hua Zou. Effects of anti-Helicobacter pylori concomitant therapy and probiotic supplementation on the throat and gut microbiota in humans. Microbial Pathogenesis 2017; 109: 156 doi: 10.1016/j.micpath.2017.05.035
|
| 29 |
Zhenhui Chen, Huijuan Chen, Lu Yu, Hongjie Xin, Jingjing Kong, Yang Bai, Weisen Zeng, Jumei Zhang, Qingping Wu, Hongying Fan. Bioinformatic identification of key pathways, hub genes, and microbiota for therapeutic intervention in Helicobacter pylori infection. Journal of Cellular Physiology 2021; 236(2): 1158 doi: 10.1002/jcp.29925
|
| 30 |
Taslima Zaman, Ahsanul Haq, Rahnuma Ahmad, Susmita Sinha, Kona Chowdhury, Sultana Parvin, Mostofa Imran, Zaman U Humayra, Santosh Kumar, Mainul Haque. The Role of Probiotics in the Eradication of Helicobacter pylori and Overall Impact on Management of Peptic Ulcer: A Study Involving Patients Undergoing Triple Therapy in Bangladesh. Cureus 2024; doi: 10.7759/cureus.56283
|
| 31 |
Susanne Jenneke Van Veen, Elvira Ingrid Levy, Koen Huysentruyt, Yvan Vandenplas. Clinical Dilemmas for the Diagnosis and Treatment of Helicobacter pylori Infection in Children: From Guideline to Practice. Pediatric Gastroenterology, Hepatology & Nutrition 2024; 27(5): 267 doi: 10.5223/pghn.2024.27.5.267
|
| 32 |
Mydhily R. B. Nair, Deepak Chouhan, Sourav Sen Gupta, Santanu Chattopadhyay. Fermented Foods: Are They Tasty Medicines for Helicobacter pylori Associated Peptic Ulcer and Gastric Cancer?. Frontiers in Microbiology 2016; 7 doi: 10.3389/fmicb.2016.01148
|
| 33 |
Ru-Jia Li, Yuan-Yuan Dai, Chun Qin, Xiao-Hua Li, Yan-Chun Qin, Yong Pan, Yong-Yi Huang, Zan-Song Huang, Yan-Qiang Huang. Treatment strategies and preventive methods for drug-resistant <i>Helicobacter pylori</i> infection. World Journal of Meta-Analysis 2020; 8(2): 98-108 doi: 10.13105/wjma.v8.i2.98
|
| 34 |
Sheila M. Wilhelm, Reem S. Aljanabi, Pramodini B. Kale-Pradhan. APhA OTC - Gastrointestinal Disorders. 2024; doi: 10.21019/aphaotc-gastro.prebiotics
|
| 35 |
M R Konorev, T M Andronova, M E Matveenko. Use of probiotics and probiotic-based immunomodulators as adjuvant therapy for Helicobacter pylori eradication. Terapevticheskii arkhiv 2016; 88(12): 140 doi: 10.17116/terarkh20168812140-148
|
| 36 |
Jung Hwan Oh. Helicobacter pyloriand Gastric Microbiota. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2016; 16(2): 59 doi: 10.7704/kjhugr.2016.16.2.59
|
| 37 |
Han-Yi Song, Long Zhou, Dong-yan Liu, Xin-Jie Yao, Yan Li. What Roles Do Probiotics Play in the Eradication of Helicobacter pylori? Current Knowledge and Ongoing Research. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/9379480
|
| 38 |
Rafael Chacon Ruiz Martinez, Raquel Bedani, Susana Marta Isay Saad. Scientific evidence for health effects attributed to the consumption of probiotics and prebiotics: an update for current perspectives and future challenges. British Journal of Nutrition 2015; 114(12): 1993 doi: 10.1017/S0007114515003864
|
| 39 |
Martin Buckley, Sean Lacey, Andrea Doolan, Emily Goodbody, Kelly Seamans. The effect of Lactobacillus reuteri supplementation in Helicobacter pylori infection: a placebo-controlled, single-blind study. BMC Nutrition 2018; 4(1) doi: 10.1186/s40795-018-0257-4
|
| 40 |
Hao-Ran Fang, Guo-Qiang Zhang, Jing-Yi Cheng, Zhong-Yue Li. Efficacy of Lactobacillus-supplemented triple therapy for Helicobacter pylori infection in children: a meta-analysis of randomized controlled trials. European Journal of Pediatrics 2019; 178(1): 7 doi: 10.1007/s00431-018-3282-z
|
| 41 |
Luisa F. Duque-Buitrago, Antonio Tornero-Martínez, Verónica Loera-Castañeda, Rosalva Mora-Escobedo. Use of food and food-derived products in the treatment of gastritis: A systematic review. Critical Reviews in Food Science and Nutrition 2023; 63(22): 5771 doi: 10.1080/10408398.2021.2024131
|
| 42 |
P Malfertheiner, F Megraud, C A O'Morain, J P Gisbert, E J Kuipers, A T Axon, F Bazzoli, A Gasbarrini, J Atherton, D Y Graham, R Hunt, P Moayyedi, T Rokkas, M Rugge, M Selgrad, S Suerbaum, K Sugano, E M El-Omar. Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report. Gut 2017; 66(1): 6 doi: 10.1136/gutjnl-2016-312288
|
| 43 |
Elena I. Ermolenko, Anastasiya S. Molostova, Natalia V. Baryshnikova, Alena V. Svarval, Nikita S. Gladyshev, Victor A. Kashchenko, Alexander N. Suvorov. The clinical effectiveness of probiotics and autoprobiotics in treatment of <i>Helicobacter pylori</i>-associated dyspepsia. Russian Journal of Infection and Immunity 2022; 12(4): 726 doi: 10.15789/2220-7619-TCE-1927
|
| 44 |
Daisy M.A.E. Jonkers. Microbial perturbations and modulation in conditions associated with malnutrition and malabsorption. Best Practice & Research Clinical Gastroenterology 2016; 30(2): 161 doi: 10.1016/j.bpg.2016.02.006
|
| 45 |
Lynne V McFarland, Ying Huang, Lin Wang, Peter Malfertheiner. Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy forHelicobacter pylorieradication and prevention of adverse events. United European Gastroenterology Journal 2016; 4(4): 546 doi: 10.1177/2050640615617358
|
| 46 |
Daniel Pohl, Peter M Keller, Valentine Bordier, Karoline Wagner. Review of current diagnostic methods and advances in <i>Helicobacter pylori</i> diagnostics in the era of next generation sequencing. World Journal of Gastroenterology 2019; 25(32): 4629-4660 doi: 10.3748/wjg.v25.i32.4629
|
| 47 |
In Young Hwang, Hui Ling Lee, James Guoxian Huang, Yvonne Yijuan Lim, Wen Shan Yew, Yung Seng Lee, Matthew Wook Chang. Engineering microbes for targeted strikes against human pathogens. Cellular and Molecular Life Sciences 2018; 75(15): 2719 doi: 10.1007/s00018-018-2827-7
|
| 48 |
Gokul D Yatheendranathan, Sudhakar Ankaiya, J Lalith Kumar. Comparative Study between Two Triple-therapy Regimens in Treating Helicobacter pylori: Related Peptic Ulcer Disease. SBV Journal of Basic, Clinical and Applied Health Science 2019; 2(3): 108 doi: 10.5005/jp-journals-10082-02222
|
| 49 |
Fanglei Zuo, Amulya Appaswamy, Hanna G. Gebremariam, Ann-Beth Jonsson. Role of Sortase A in Lactobacillus gasseri Kx110A1 Adhesion to Gastric Epithelial Cells and Competitive Exclusion of Helicobacter pylori. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.02770
|
| 50 |
Majid Eslami, Bahman Yousefi, Parviz Kokhaei, Ali Jazayeri Moghadas, Bizhan Sadighi Moghadam, Vahid Arabkari, Zohreh Niazi. Are probiotics useful for therapy of Helicobacter pylori diseases?. Comparative Immunology, Microbiology and Infectious Diseases 2019; 64: 99 doi: 10.1016/j.cimid.2019.02.010
|
| 51 |
M. R. Konorev, E. N. Tyshevich, R. A. Pavlyukov. Application of N-Acetyl-Glucosaminil-N-Acetyl-Muramyl Dipeptide during Triple Component Anti-Helicobacter Pylori Therapy in the Period of Coronavirus Infection COVID-19. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2023; 33(2): 60 doi: 10.22416/1382-4376-2023-33-2-60-69
|
| 52 |
Chao Lu, Jianzhong Sang, Haijian He, Xingyong Wan, Yiming Lin, Lan Li, Youming Li, Chaohui Yu. Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis. Scientific Reports 2016; 6(1) doi: 10.1038/srep23522
|
| 53 |
Sheila Wilhelm, Pramodini Kale-Pradhan. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 20th Edition. 2020; doi: 10.21019/9781582123172.ch20
|
| 54 |
Mohammadreza Rabiee, Masoumeh Sadat Mousavi. Tendency to Consume Probiotics in the General Population: An Ecological Study. Modern Care Journal 2024; 21(3) doi: 10.5812/mcj-143404
|
| 55 |
Javier P. Gisbert, Javier Alcedo, Javier Amador, Luis Bujanda, Xavier Calvet, Manuel Castro-Fernández, Luis Fernández-Salazar, Emili Gené, Ángel Lanas, Alfredo Lucendo, Javier Molina-Infante, Olga P. Nyssen, A. Pérez-Aisa, Ignasi Puig. V Spanish Consensus Conference on Helicobacter pylori infection treatment. Gastroenterología y Hepatología (English Edition) 2022; 45(5): 392 doi: 10.1016/j.gastre.2021.07.001
|
| 56 |
Javier P. Gisbert, Javier Molina-Infante, Javier Amador, Fernando Bermejo, Luis Bujanda, Xavier Calvet, Manuel Castro-Fernández, Antonio Cuadrado-Lavín, J. Ignasi Elizalde, Emili Gene, Fernando Gomollón, Ángel Lanas, Carlos Martín de Argila, Fermín Mearin, Miguel Montoro, Ángeles Pérez-Aisa, Emilio Pérez-Trallero, Adrián G. McNicholl. IV Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori. Gastroenterología y Hepatología 2016; 39(10): 697 doi: 10.1016/j.gastrohep.2016.05.003
|
| 57 |
Ben‐Gang Zhou, Ling‐Xiao Chen, Bo Li, Lin‐Yan Wan, Yao‐Wei Ai. Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis with trial sequential analysis. Helicobacter 2019; 24(5) doi: 10.1111/hel.12651
|
| 58 |
Aleksandra Sokic-Milutinovic, Tamara Alempijevic, Tomica Milosavljevic. Role of <italic>Helicobacter pylori</italic> infection in gastric carcinogenesis: Current knowledge and future directions. World Journal of Gastroenterology 2015; 21(41): 11654-11672 doi: 10.3748/wjg.v21.i41.11654
|
| 59 |
Cristina Maria Marginean, Ramona Cioboata, Mihai Olteanu, Corina Maria Vasile, Mihaela Popescu, Alin Iulian Silviu Popescu, Simona Bondari, Denisa Pirscoveanu, Iulia Cristina Marginean, George Alexandru Iacob, Mihai Daniel Popescu, Mihaela Stanciu, Paul Mitrut. The Importance of Accurate Early Diagnosis and Eradication in Helicobacter pylori Infection: Pictorial Summary Review in Children and Adults. Antibiotics 2022; 12(1): 60 doi: 10.3390/antibiotics12010060
|
| 60 |
Manuel Plomer, Marcos III Perez, Dorothea Maren Greifenberg. Effect of Bacillus clausii Capsules in Reducing Adverse Effects Associated with Helicobacter pylori Eradication Therapy: A Randomized, Double-Blind, Controlled Trial. Infectious Diseases and Therapy 2020; 9(4): 867 doi: 10.1007/s40121-020-00333-2
|
| 61 |
Uday C Ghoshal, Kok‐Ann Gwee, Gerald Holtmann, Yanmei Li, Soo Jung Park, Marcellus Simadibrata, Kentaro Sugano, Kaichun Wu, Eamonn M M Quigley, Henry Cohen. The role of the microbiome and the use of probiotics in gastrointestinal disorders in adults in the Asia‐Pacific region ‐ background and recommendations of a regional consensus meeting. Journal of Gastroenterology and Hepatology 2018; 33(1): 57 doi: 10.1111/jgh.13840
|
| 62 |
Maja Šikić Pogačar, Dušanka Mičetić-Turk, Sabina Fijan. Probiotics in the Prevention and Management of Human Diseases. 2022; : 465 doi: 10.1016/B978-0-12-823733-5.00021-0
|
| 63 |
Nicoleta-Maricica Maftei. Frontiers and New Trends in the Science of Fermented Food and Beverages. 2019; doi: 10.5772/intechopen.81553
|
| 64 |
Lorenzo Morelli, Maria L. Callegari, Vania Patrone. The Bifidobacteria and Related Organisms. 2018; : 271 doi: 10.1016/B978-0-12-805060-6.00017-X
|
| 65 |
Tiantian Shan, Xi Chen, Xinxuan Zhou, Nanxi Wang, Biao Ren, Lei Cheng. Stimulus-responsive biomaterials for Helicobacter pylori eradication. Journal of Advanced Research 2023; doi: 10.1016/j.jare.2023.12.019
|
| 66 |
Todor Asenov Angelov, Mila Dimitrova Kovacheva-Slavova, Hristo Ilianov Iliev, Hristo Yankov Valkov, Borislav Georgiev Vladimirov. Gastritis - New Approaches and Treatments. 2019; doi: 10.5772/intechopen.86963
|
| 67 |
Yun Lu, Shuqi Xing, Laping He, Cuiqin Li, Xiao Wang, Xuefeng Zeng, Yifeng Dai. Characterization, High-Density Fermentation, and the Production of a Directed Vat Set Starter of Lactobacilli Used in the Food Industry: A Review. Foods 2022; 11(19): 3063 doi: 10.3390/foods11193063
|
| 68 |
A. G. Kononova, S. V. Kolbasnikov, S. N. Beldiev. The role of probiotics in <i>Helicobacter pylori</i> eradication therapy regimens: current evidence of eff ectiveness. Experimental and Clinical Gastroenterology 2022; (4): 160 doi: 10.31146/1682-8658-ecg-200-4-160-168
|
| 69 |
Meng Li, Xiaolei Wang, Xinhong Dong, Guigen Teng, Yun Dai, Weihong Wang. Lactobacillus reuteri compared with placebo as an adjuvant in Helicobacter pylori eradication therapy: a meta-analysis of randomized controlled trials. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241258021
|
| 70 |
Fahad Alsohaibani, Musthafa Peedikayil, Abdulaziz Alshahrani, Ali Somily, Raed Alsulaiman, Nahla Azzam, Majid Almadi. Practice guidelines for the management of Helicobacter pylori infection: The Saudi H. pylori Working Group recommendations. Saudi Journal of Gastroenterology 2023; 29(6): 326 doi: 10.4103/sjg.sjg_288_22
|
| 71 |
Wen Ji, Wei-Qing Chen, Xu Tian. Efficacy of compoundLactobacillus acidophilustablets combined with quadruple therapy forHelicobacter pylorieradication and its correlation with pH value in the stomach: a study protocol of a randomised, assessor-blinded, single-centre study. BMJ Open 2018; 8(10): e023131 doi: 10.1136/bmjopen-2018-023131
|
| 72 |
T. Barani Devi, Krishnadas Devadas, Meekha George, A. Gandhimathi, Deepak Chouhan, R. J. Retnakumar, Sneha Mary Alexander, Jijo Varghese, Sanjai Dharmaseelan, Sivakumar Krishnankutty Chandrika, V. T. Jissa, Bhabatosh Das, G. Balakrish Nair, Santanu Chattopadhyay. Low Bifidobacterium Abundance in the Lower Gut Microbiota Is Associated With Helicobacter pylori-Related Gastric Ulcer and Gastric Cancer. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.631140
|
| 73 |
Chenghai Yang, Liping Liang, Pinjing Lv, Le Liu, Siqi Wang, Zhiqing Wang, Ye Chen. Effects of non‐viableLactobacillus reutericombining with 14‐day standard triple therapy onHelicobacter pylorieradication: A randomized double‐blind placebo‐controlled trial. Helicobacter 2021; 26(6) doi: 10.1111/hel.12856
|
| 74 |
Dana Westmeier, Gernot Posselt, Angelina Hahlbrock, Sina Bartfeld, Cecilia Vallet, Carmen Abfalter, Dominic Docter, Shirley K. Knauer, Silja Wessler, Roland H. Stauber. Nanoparticle binding attenuates the pathobiology of gastric cancer-associatedHelicobacter pylori. Nanoscale 2018; 10(3): 1453 doi: 10.1039/C7NR06573F
|
| 75 |
V.A. Andreev, Olga U. Stetsiouk, Irina V. Andreeva. Probiotics: controversial issues. Clinical Microbiology and Antimicrobial Chemotherapy 2022; 24(4): 345 doi: 10.36488/cmac.2022.4.345-360
|
| 76 |
Jonathan Takahashi, J. Adam Rindfleisch. Integrative Medicine. 2018; : 986 doi: 10.1016/B978-0-323-35868-2.00105-5
|
| 77 |
Chao Peng, Yi Hu, Zhong‐Ming Ge, Quan‐Ming Zou, Nong‐Hua Lyu. Diagnosis and treatment ofHelicobacter pyloriinfections in children and elderly populations. Chronic Diseases and Translational Medicine 2019; 5(4): 243 doi: 10.1016/j.cdtm.2019.12.003
|
| 78 |
Lorena Elena Meliț, Cristina Oana Mărginean, Maria Oana Săsăran. The Challenges of Eradicating Pediatric Helicobacter pylori Infection in the Era of Probiotics. Children 2022; 9(6): 795 doi: 10.3390/children9060795
|
| 79 |
Javier P. Gisbert, Javier Molina-Infante, Javier Amador, Fernando Bermejo, Luis Bujanda, Xavier Calvet, Manuel Castro-Fernández, Antonio Cuadrado-Lavín, J. Ignasi Elizalde, Emili Gene, Fernando Gomollón, Ángel Lanas, Carlos Martín de Argila, Fermín Mearin, Miguel Montoro, Ángeles Pérez-Aisa, Emilio Pérez-Trallero, Adrián G. McNicholl. IV Spanish Consensus Conference on Helicobacter pylori infection treatment. Gastroenterología y Hepatología (English Edition) 2016; 39(10): 697 doi: 10.1016/j.gastre.2016.11.007
|
| 80 |
Masoud Keikha, Mohsen Karbalaei. Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01977-1
|
| 81 |
Qian Zhao, Wen-jia Wang, Shui-ping Zhou, Jing Su, He Sun, Jing-bo Zhai, Yun-hui Hu. Jinghua Weikang capsule for helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.959184
|
| 82 |
William D Chey, Grigorios I Leontiadis, Colin W Howden, Steven F Moss. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. American Journal of Gastroenterology 2017; 112(2): 212 doi: 10.1038/ajg.2016.563
|
| 83 |
Maria Rosa Machado Prado, Christian Boller. Discovery and Development of Anti-Inflammatory Agents from Natural Products. 2019; : 259 doi: 10.1016/B978-0-12-816992-6.00009-7
|
| 84 |
Rekha Kumari, Archana Singh, Ajar Nath Yadav, Shashank Mishra, Ashish Sachan, Shashwati Ghosh Sachan. New and Future Developments in Microbial Biotechnology and Bioengineering. 2020; : 173 doi: 10.1016/B978-0-12-820528-0.00012-0
|
| 85 |
Jae Hyun Jung, In Kuk Cho, Chang Hee Lee, Gwan Gyu Song, Ji Hyun Lim. Clinical Outcomes of Standard Triple Therapy Plus Probiotics or Concomitant Therapy for Helicobacter pylori Infection. Gut and Liver 2018; 12(2): 165 doi: 10.5009/gnl17177
|
| 86 |
Alejandro Venegas, Jorge Hantar Touma, Jessica Bravo, Guillermo Perez-Perez. Progress in Use of Natural Products and Their Active Components against <i>Helicobacter pylori</i>. Advances in Microbiology 2016; 6(14): 1091 doi: 10.4236/aim.2016.614101
|
| 87 |
Kashyapi Chakravarty, Smriti Gaur. Role of Probiotics in Prophylaxis of Helicobacter pylori Infection. Current Pharmaceutical Biotechnology 2019; 20(2): 137 doi: 10.2174/1389201020666190227203107
|
| 88 |
Roujie Huang, Fei Wu, Qian Zhou, Wei Wei, Juan Yue, Bo Xiao, Zhaohui Luo. Lactobacillus and intestinal diseases: Mechanisms of action and clinical applications. Microbiological Research 2022; 260: 127019 doi: 10.1016/j.micres.2022.127019
|
| 89 |
Luigi Santacroce, Ioannis Alexandros Charitos, Lucrezia Bottalico. A successful history: probiotics and their potential as antimicrobials. Expert Review of Anti-infective Therapy 2019; 17(8): 635 doi: 10.1080/14787210.2019.1645597
|
| 90 |
Juan José Sebastián Domingo. Revisión del papel de los probióticos en la patología gastrointestinal del adulto. Gastroenterología y Hepatología 2017; 40(6): 417 doi: 10.1016/j.gastrohep.2016.12.003
|
| 91 |
Guzel Sh. Isaeva, R.A. Isaeva. Mechanisms of microbial interactions between probiotic microorganisms
and Helicobacter pylori. Clinical Microbiology and Antimicrobial Chemotherapy 2023; 25(3): 225 doi: 10.36488/cmac.2023.3.225-238
|
| 92 |
Marjan Mokhtare, Mohammad Ebrahimian, Abolfazl Namazi, Amir M. Sadeghian, Hani Talaee, Mohsen Masoodi, Jiong Yu. The Efficacy of Paraprobiotic, Probiotic, and Mineral Supplementation on the Eradication Rate of Helicobacter pylori in Patients with Dyspepsia: A Randomized Clinical Trial. Advanced Gut & Microbiome Research 2024; 2024: 1 doi: 10.1155/2024/9936691
|
| 93 |
Doron Boltin. Probiotics in Helicobacter pylori-induced peptic ulcer disease. Best Practice & Research Clinical Gastroenterology 2016; 30(1): 99 doi: 10.1016/j.bpg.2015.12.003
|
| 94 |
Zihan Yang, Yueyang Zhou, Ziying Han, Kun He, Yuelun Zhang, Dong Wu, Hongda Chen. The effects of probiotics supplementation on Helicobacter pylori standard treatment: an umbrella review of systematic reviews with meta-analyses. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-59399-4
|
| 95 |
E. Ng, J.R.H. Tay, M.M.A. Ong, N. Bostanci, G.N. Belibasakis, C.J. Seneviratne. Probiotic therapy for periodontal and peri-implant health – silver bullet or sham?. Beneficial Microbes 2021; 12(3): 215 doi: 10.3920/BM2020.0182
|
| 96 |
Javier P. Gisbert, Javier Alcedo, Javier Amador, Luis Bujanda, Xavier Calvet, Manuel Castro-Fernández, Luis Fernández-Salazar, Emili Gené, Ángel Lanas, Alfredo J. Lucendo, Javier Molina-Infante, Olga P. Nyssen, A. Pérez-Aisa, Ignasi Puig. V Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori. Gastroenterología y Hepatología 2022; 45(5): 392 doi: 10.1016/j.gastrohep.2021.07.011
|
| 97 |
Petruta Violeta Filip, Denisa Cuciureanu, Laura Sorina Diaconu, Ana Maria Vladareanu, Corina Silvia Pop. MALT lymphoma: epidemiology, clinical diagnosis and treatment. Journal of Medicine and Life 2018; 11(3): 187 doi: 10.25122/jml-2018-0035
|
| 98 |
Giuseppe Losurdo, Rossella Cubisino, Michele Barone, Mariabeatrice Principi, Gioacchino Leandro, Enzo Ierardi, Alfredo Di Leo. Probiotic monotherapy and <i>Helicobacter pylori</i> eradication: A systematic review with pooled-data analysis. World Journal of Gastroenterology 2018; 24(1): 139-149 doi: 10.3748/wjg.v24.i1.139
|
| 99 |
Angitha N. Nath, R. J. Retnakumar, Ashik Francis, Prakash Chhetri, Namrata Thapa, Santanu Chattopadhyay. Peptic Ulcer and Gastric Cancer: Is It All in the Complex Host–Microbiome Interplay That Is Encoded in the Genomes of “Us” and “Them”?. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.835313
|
| 100 |
Juan José Sebastián Domingo. Review of the role of probiotics in gastrointestinal diseases in adults. Gastroenterología y Hepatología (English Edition) 2017; 40(6): 417 doi: 10.1016/j.gastre.2016.12.001
|
| 101 |
Paúl A. Cárdenas, Daniela Garcés, Belén Prado-Vivar, Nancy Flores, Marco Fornasini, Henry Cohen, Iván Salvador, Oswaldo Cargua, Manuel E. Baldeón. Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome. European Journal of Clinical Microbiology & Infectious Diseases 2020; 39(7): 1365 doi: 10.1007/s10096-020-03854-3
|
| 102 |
Pramodini Kale-Pradhan, Sheila Wilhelm. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 19th Edition. 2017; doi: 10.21019/9781582122656.ch20
|
| 103 |
Elizaveta A. Trush, Elena A. Poluektova, Allan G. Beniashvilli, Oleg S. Shifrin, Yuri M. Poluektov, Vladimir T. Ivashkin. The Evolution of Human Probiotics: Challenges and Prospects. Probiotics and Antimicrobial Proteins 2020; 12(4): 1291 doi: 10.1007/s12602-019-09628-4
|
| 104 |
Aslı AKPINAR, Gizem ERK, Ahmet SEVEN. VEGAN VE VEJETARYAN BESLENMEDE PROBİYOTİK BİTKİSEL BAZLI SÜT ÜRÜNLERİNİN YERİ. Gıda 2019; 44(3): 453 doi: 10.15237/gida.GD18083
|
| 105 |
Irina Luzko, Olga P. Nyssen, Leticia Moreira, Javier P. Gisbert.
Safety profile of
Helicobacter pylori
eradication treatments: literature review and updated data of the European Registry on
Helicobacter pylori
management (Hp-EuReg)
. Expert Opinion on Drug Safety 2024; 23(5): 553 doi: 10.1080/14740338.2024.2338245
|
| 106 |
Omnia Momtaz Al-Fakhrany, Engy Elekhnawy. Helicobacter pylori in the post-antibiotics era: from virulence factors to new drug targets and therapeutic agents. Archives of Microbiology 2023; 205(9) doi: 10.1007/s00203-023-03639-0
|
| 107 |
I. W. Fong. Current Trends and Concerns in Infectious Diseases. 2020; : 81 doi: 10.1007/978-3-030-36966-8_4
|
| 108 |
Wen Zhong Liu, Yong Xie, Hong Lu, Hong Cheng, Zhi Rong Zeng, Li Ya Zhou, Ye Chen, Jiang Bin Wang, Yi Qi Du, Nong Hua Lu. Fifth Chinese National Consensus Report on the management ofHelicobacter pyloriinfection. Helicobacter 2018; 23(2) doi: 10.1111/hel.12475
|
| 109 |
Ahmed G. Abdelhamid. Probiotics could pay off in Helicobacter pylori eradication. Drugs & Therapy Perspectives 2020; 36(1): 23 doi: 10.1007/s40267-019-00684-y
|
| 110 |
Majid T. Moghadam, Zahra Chegini, Amin Norouzi, Amin S. Dousari, Aref Shariati. Three-Decade Failure to the Eradication of Refractory Helicobacter pylori Infection and Recent Efforts to Eradicate the Infection. Current Pharmaceutical Biotechnology 2021; 22(7): 945 doi: 10.2174/1389201021666200807110849
|
| 111 |
Toru Hiyama, Masaki Kunihiro, Naoki Asayama, Yuji Urabe, Hideharu Okanobu, Seiji Onogawa, Kayoko Kunihiro, Toshio Kuwai, Michiyo Kodama, Yoji Sanomura, Kenta Nagai, Hiroshige Hamada, Akira Furudoi, Tomohiro Miwata, Ritsuo Mouri, Kyoko Yoshioka, Shinji Tanaka, Shiro Oka. Hiroshima University Affiliated Hospital Probiotics Usage Guidelines. Nippon Daicho Komonbyo Gakkai Zasshi 2023; 76(7): 467 doi: 10.3862/jcoloproctology.76.467
|
| 112 |
Eric Guillemard, Marion Poirel, Florent Schäfer, Laurent Quinquis, Caroline Rossoni, Christian Keicher, Frank Wagner, Hania Szajewska, Frédéric Barbut, Muriel Derrien, Peter Malfertheiner. A Randomised, Controlled Trial: Effect of a Multi-Strain Fermented Milk on the Gut Microbiota Recovery after Helicobacter pylori Therapy. Nutrients 2021; 13(9): 3171 doi: 10.3390/nu13093171
|
| 113 |
Duygu Ağagündüz, Fatma Nur Keskin. Handbook of Sourdough Microbiota and Fermentation. 2025; : 161 doi: 10.1016/B978-0-443-18622-6.00009-8
|
| 114 |
Adrian G. McNicholl, Javier Molina‐Infante, Alfredo J. Lucendo, José Luis Calleja, Ángeles Pérez‐Aisa, Inés Modolell, Xavier Aldeguer, Margalida Calafat, Luis Comino, Mercedes Ramas, Ángel Callejo, Carlos Badiola, Jordi Serra, Javier P. Gisbert. Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double‐blind, placebo‐controlled trial. Helicobacter 2018; 23(5) doi: 10.1111/hel.12529
|
| 115 |
Monica Profir, Oana Alexandra Roşu, Ruxandra Florentina Ionescu, Luciana Alexandra Pavelescu, Sanda Maria Cretoiu. Antidotes to Toxins and Drugs. 2024; : 279 doi: 10.1016/B978-0-12-824472-2.00011-7
|
| 116 |
V. Т. Ivashkin, A. I. Ulyanin, I. V. Mayev, R. S. Kozlov, M. A. Livzan, S. R. Abdulkhakov, O. P. Alekseyeva, S. A. Alekseyenko, D. S. Bordin, N. N. Dekhnich, N. V. Korochyanskaya, T. L. Lapina, E. A. Poluektova, V. I. Simanenkov, A. S. Trukhmanov, I. B. Khlynov, V. V. Tsukanov, A. A. Sheptulin. Modern Approaches to <i>H. pylori</i> Eradication Therapy in Adults (Literature Review and Resolution of Experts Council). Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(6): 7 doi: 10.22416/1382-4376-2022-32-6-7-19
|
| 117 |
|
| 118 |
D. Westmeier, A. Hahlbrock, C. Reinhardt, J. Fröhlich-Nowoisky, S. Wessler, C. Vallet, U. Pöschl, S. K. Knauer, R. H. Stauber. Nanomaterial–microbe cross-talk: physicochemical principles and (patho)biological consequences. Chemical Society Reviews 2018; 47(14): 5312 doi: 10.1039/C6CS00691D
|
| 119 |
Laure Brigitte Kouitcheu Mabeku, Samuel Ngue, Idris Bonsou Nguemo, Hubert Leundji. Potential of selected lactic acid bacteria from Theobroma cacao fermented fruit juice and cell-free supernatants from cultures as inhibitors of Helicobacter pylori and as good probiotic. BMC Research Notes 2020; 13(1) doi: 10.1186/s13104-020-4923-7
|
| 120 |
Xiaoguang Shi, Junhong Zhang, Lingshan Mo, Jialing Shi, Mengbin Qin, Xue Huang. Efficacy and safety of probiotics in eradicating Helicobacter pylori. Medicine 2019; 98(15): e15180 doi: 10.1097/MD.0000000000015180
|
| 121 |
María Guerra-Valle, Patricio Orellana-Palma, Guillermo Petzold. Plant-Based Polyphenols: Anti-Helicobacter pylori Effect and Improvement of Gut Microbiota. Antioxidants 2022; 11(1): 109 doi: 10.3390/antiox11010109
|
| 122 |
Cesar de la Fuente-Nunez, Angela Cesaro, Robert E.W. Hancock. Antibiotic failure: Beyond antimicrobial resistance. Drug Resistance Updates 2023; 71: 101012 doi: 10.1016/j.drup.2023.101012
|
| 123 |
Svenja Siemer, Angelina Hahlbrock, Cecilia Vallet, David Julian McClements, Jan Balszuweit, Jens Voskuhl, Dominic Docter, Silja Wessler, Shirley K. Knauer, Dana Westmeier, Roland H. Stauber. Nanosized food additives impact beneficial and pathogenic bacteria in the human gut: a simulated gastrointestinal study. npj Science of Food 2018; 2(1) doi: 10.1038/s41538-018-0030-8
|
| 124 |
Antone R. Opekun, Savannah A. Gonzales, Mahmoud A. Al‐Saadi, David Y. Graham. Brief report: Lactobacillus bulgaricus GLB44 (Proviotic™) plus esomeprazole for Helicobacter pylori eradication: A pilot study. Helicobacter 2018; 23(2) doi: 10.1111/hel.12476
|
| 125 |
Sadia Alvi, Aqeel Javeed, Bushra Akhtar, Ali Sharif, Muhammad Furqan Akhtar. Probiotics for cure of Helicobacter pylori infection: A review. International Journal of Food Properties 2017; 20(10): 2215 doi: 10.1080/10942912.2016.1233432
|